Many Patients With Advanced MCC Not Receiving Immunotherapy
Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/many-patients-advanced-mcc-not-receiving-immunotherapy-2024a10008ne?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/many-patients-advanced-mcc-not-receiving-immunotherapy-2024a10008ne?src=rss
Comments
Post a Comment